Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
about
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasThe chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice.High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentAutologous hematopoietic stem cell transplantation for pediatric solid tumors.The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas.High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group.High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.Advances in emerging drugs for osteosarcoma.Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital.High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.High-dose thiotepa-related neurotoxicity and the role of tramadol in children.
P2860
Q24234049-2D5921D1-30EC-4FED-B033-9F0A3233D21FQ33703348-C4D8D27E-C41B-40A5-B504-107BEE7C2A7DQ33836798-24B57978-6E33-4757-9227-39E84DDABF25Q35958048-AD78CC94-4E24-4C24-9C67-9867F87A15AAQ36284506-7434628A-E37F-48F6-B144-ECD142F56C1FQ36381282-8C0A8993-CB0A-41A6-B543-A8395ECB3147Q37615003-26A4BC87-4F31-4888-B46A-65F5EDB7C009Q37845833-9CF72DF4-A77D-4924-90D2-3066C0072F58Q38506118-BDF1CEA3-A4C4-4D56-9A02-6F5FE05FB1E8Q40367223-BD5D7349-BCAA-4021-ADBB-E995979E8E99Q43185074-73093A87-B5AD-4257-B9B3-51064233832BQ43661037-7252D018-C0B0-4B8A-AA13-C83303282A6EQ43770759-9CC5F32C-7A19-4F98-ADDA-262F70DDD138Q44351264-31F391C2-8C05-4707-97E1-967F187CF937Q45911250-964B83C1-7D3C-4DF9-9991-D22083902D4EQ50046503-EB95BC48-1553-4663-BFCA-A4E48BBFC691
P2860
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Phase II study of high-dose th ...... in children with solid tumors.
@ast
Phase II study of high-dose th ...... in children with solid tumors.
@en
type
label
Phase II study of high-dose th ...... in children with solid tumors.
@ast
Phase II study of high-dose th ...... in children with solid tumors.
@en
prefLabel
Phase II study of high-dose th ...... in children with solid tumors.
@ast
Phase II study of high-dose th ...... in children with solid tumors.
@en
P2093
P356
P1476
Phase II study of high-dose th ...... in children with solid tumors.
@en
P2093
Beaujean F
Hartmann O
Lapierre V
Lucidarme N
Valteau-Couanet D
P2888
P304
P356
10.1038/SJ.BMT.1701395
P407
P577
1998-09-01T00:00:00Z
P5875
P6179
1029780501